MATA NATHAN L. 4
4 · BELITE BIO, INC · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
BELITE BIO (BLTE) CSO Nathan L. Mata Sells Shares
What Happened Nathan L. Mata, Chief Scientific Officer of Belite Bio, sold a total of 1,000 American depositary shares (ADS) in open-market transactions on May 4, 2026, for aggregate proceeds of approximately $155,635. The sales were reported in five lots:
- 32 ADS at $153.50 — $4,912
- 236 ADS at $154.24 — $36,400
- 325 ADS at $155.21 — $50,442
- 235 ADS at $156.57 — $36,793
- 172 ADS at $157.49 — $27,088
This was a sale (transaction code S), not a purchase or option exercise.
Key Details
- Transaction date: 2026-05-04 (Form 4 filed 2026-05-05 — appears timely).
- Price ranges (per footnotes): sales in these lots occurred within $153.05–$157.98 overall; each lot has its own narrower range (see footnotes F3–F7).
- Total shares sold: 1,000 ADS; total proceeds: ~$155,635.
- Shares owned after transaction: not disclosed in the information provided.
- Notable footnotes: F1 — each ADS represents one ordinary share; F2 — sales were effected under a Rule 10b5-1 trading plan adopted 12/10/2025; F3–F7 — weighted-average prices and price ranges, with undertaking to provide per-price breakdown if requested.
- Transaction type: Open-market sale under a pre-established 10b5-1 plan (S).
Context An ADS equals one ordinary share of the issuer. Sales executed under a 10b5-1 plan are pre-arranged trading programs that often indicate trades were scheduled in advance rather than based on contemporaneous insider knowledge; they are common for executives. Sales are routine insider activity and, by themselves, do not prove management sentiment about the company.
Insider Transaction Report
- Sale
American depositary share
[F1][F2][F3]2026-05-04$153.50/sh−32$4,912→ 3,634 total - Sale
American depositary share
[F1][F2][F4]2026-05-04$154.24/sh−236$36,400→ 3,398 total - Sale
American depositary share
[F1][F2][F5]2026-05-04$155.21/sh−325$50,442→ 3,073 total - Sale
American depositary share
[F1][F2][F6]2026-05-04$156.57/sh−235$36,793→ 2,838 total - Sale
American depositary share
[F1][F2][F7]2026-05-04$157.49/sh−172$27,088→ 2,666 total
Footnotes (7)
- [F1]Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.
- [F3]Represents the weighted average price of shares sold at prices that ranged from $153.05 to $153.855. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F4]Represents the weighted average price of shares sold at prices that ranged from $154.06 to $154.925. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F5]Represents the weighted average price of shares sold at prices that ranged from $155.02 to $155.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F6]Represents the weighted average price of shares sold at prices that ranged from $156 to $156.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F7]Represents the weighted average price of shares sold at prices that ranged from $157.05 to $157.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.